Prognostic significance of immunohistochemical markers in adrenocortical carcinoma. Issue 1 (2nd January 2020)

• Record Type: Journal Article
• Authors: Zlatibor, Loncar; Paunovic, Ivan; Zivaljevic, Vladan; Dundjerovic, Dusko; Tatic, Svetislav; Djukic, Vladimir
• Is Part Of: Acta chirurgica belgica. Volume 120:Issue 1(2020)
• Page Start: 23
• Page End: 29
• Publication Date: 2020-01-02
• Subjects: Adrenal gland -- survival -- melan A -- inhibin -- calretinin -- synaptophysin; Surgery -- Periodicals; General Surgery; Chirurgie -- Périodiques; Surgery; Chirurgie (geneeskunde); Periodicals; Periodicals; 617.005
• DOI: 10.1080/00015458.2018.1543822
• Languages: English
• ISSNs: 0001-5458

Abstract

Abstract: Background: To present basic demographic and clinical characteristics of patients with adrenocortical carcinoma (ACC), to determine the overall survival rate and to analyze the results of immunohistochemical staining and its correlation with the length of survival. Material and methods: The study was conducted during the period between 1996 and 2010 and included 30 patients with ACC. Immunohistochemical staining (MMP9, melan A, inhibin, caltretinin, D2-40, synaptophysin and Ki-67) was performed. Results: ACC was diagnosed in 19 females and 11 men (1.7:1). The average age was 50.1 years. The median tumor size was 10 cm, the median weight 400 g. Majority of subjects had positive immunohistochemical staining for the markers of interest. Patients with any negative staining had shorter cancer-specific survival than ones with positive staining. According to the log-rank test results as well as according to the results of the univariate Cox analysis, negative staining for inhibin, D2-40 and synaptophysin and Ki-67 expression ≥7% were associated with poorer prognosis. Conclusions: The results of our study suggest that the absence of staining for some immunohistochemical markers and increased expression of Ki-67 are associated with a poorer prognosis and shorter survival of patients with ACC. Immunohistochemical markers may serve as a prognostic factor for ACC.